 | • レポートコード：GIR-105X12938 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、経口用タンパク質・ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口用タンパク質・ペプチドの種類別市場規模（リナクロチド、カルシトニン、インスリン、オクトレオチド）、用途別市場規模（胃腸障害、骨疾患、糖尿病、ホルモン障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経口用タンパク質・ペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan、AstraZeneca、Biocon、Generex Biotechnology、Novo Nordisk、Synergy Pharmaceuticals、Tarsa Therapeutics、Sanofi、Hoffmann-La Roche、Synthetic Biologics、Hovione、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リナクロチド、カルシトニン、インスリン、オクトレオチド ・用途別分析2016年-2026年：胃腸障害、骨疾患、糖尿病、ホルモン障害 ・経口用タンパク質・ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口用タンパク質・ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口用タンパク質・ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口用タンパク質・ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口用タンパク質・ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Proteins and Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oral Proteins and Peptides size is estimated to be xx million in 2021 from USD 773.5 million in 2020, with a change of XX% between 2020 and 2021. The global Oral Proteins and Peptides market size is expected to grow at a CAGR of 6.3% for the next five years.
Market segmentation
Oral Proteins and Peptides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Linaclotide
Calcitonin
Insulin
Octreotide
Market segment by Application can be divided into
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
The key market players for global Oral Proteins and Peptides market are listed below:
Allergan
AstraZeneca
Biocon
Generex Biotechnology
Novo Nordisk
Synergy Pharmaceuticals
Tarsa Therapeutics
Sanofi
Hoffmann-La Roche
Synthetic Biologics
Hovione
Novartis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oral Proteins and Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Proteins and Peptides, with price, sales, revenue and global market share of Oral Proteins and Peptides from 2019 to 2021.
Chapter 3, the Oral Proteins and Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Proteins and Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oral Proteins and Peptides market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oral Proteins and Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oral Proteins and Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Proteins and Peptides Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Linaclotide
1.2.3 Calcitonin
1.2.4 Insulin
1.2.5 Octreotide
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Proteins and Peptides Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Global Oral Proteins and Peptides Market Size & Forecast
1.4.1 Global Oral Proteins and Peptides Sales in Value (2016-2026))
1.4.2 Global Oral Proteins and Peptides Sales in Volume (2016-2026)
1.4.3 Global Oral Proteins and Peptides Price by Type (2016-2026) & (USD/MT)
1.5 Global Oral Proteins and Peptides Production Capacity Analysis
1.5.1 Global Oral Proteins and Peptides Total Production Capacity (2016-2026)
1.5.2 Global Oral Proteins and Peptides Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Proteins and Peptides Market Drivers
1.6.2 Oral Proteins and Peptides Market Restraints
1.6.3 Oral Proteins and Peptides Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Oral Proteins and Peptides Product and Services
2.1.4 Allergan Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Oral Proteins and Peptides Product and Services
2.2.4 AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Oral Proteins and Peptides Product and Services
2.3.4 Biocon Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Generex Biotechnology
2.4.1 Generex Biotechnology Details
2.4.2 Generex Biotechnology Major Business
2.4.3 Generex Biotechnology Oral Proteins and Peptides Product and Services
2.4.4 Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Oral Proteins and Peptides Product and Services
2.5.4 Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Synergy Pharmaceuticals
2.6.1 Synergy Pharmaceuticals Details
2.6.2 Synergy Pharmaceuticals Major Business
2.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Product and Services
2.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Tarsa Therapeutics
2.7.1 Tarsa Therapeutics Details
2.7.2 Tarsa Therapeutics Major Business
2.7.3 Tarsa Therapeutics Oral Proteins and Peptides Product and Services
2.7.4 Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Oral Proteins and Peptides Product and Services
2.8.4 Sanofi Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Hoffmann-La Roche
2.9.1 Hoffmann-La Roche Details
2.9.2 Hoffmann-La Roche Major Business
2.9.3 Hoffmann-La Roche Oral Proteins and Peptides Product and Services
2.9.4 Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Synthetic Biologics
2.10.1 Synthetic Biologics Details
2.10.2 Synthetic Biologics Major Business
2.10.3 Synthetic Biologics Oral Proteins and Peptides Product and Services
2.10.4 Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Hovione
2.11.1 Hovione Details
2.11.2 Hovione Major Business
2.11.3 Hovione Oral Proteins and Peptides Product and Services
2.11.4 Hovione Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Novartis
2.12.1 Novartis Details
2.12.2 Novartis Major Business
2.12.3 Novartis Oral Proteins and Peptides Product and Services
2.12.4 Novartis Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oral Proteins and Peptides Sales by Manufacturer
3.1 Global Oral Proteins and Peptides Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral Proteins and Peptides Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral Proteins and Peptides
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Proteins and Peptides Manufacturer Market Share
3.4.2 Top 6 Oral Proteins and Peptides Manufacturer Market Share
3.5 Global Oral Proteins and Peptides Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral Proteins and Peptides Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Proteins and Peptides Market Size by Region
4.1.1 Global Oral Proteins and Peptides Sales in Volume by Region (2016-2026)
4.1.2 Global Oral Proteins and Peptides Revenue by Region (2016-2026)
4.2 North America Oral Proteins and Peptides Revenue (2016-2026)
4.3 Europe Oral Proteins and Peptides Revenue (2016-2026)
4.4 Asia-Pacific Oral Proteins and Peptides Revenue (2016-2026)
4.5 South America Oral Proteins and Peptides Revenue (2016-2026)
4.6 Middle East and Africa Oral Proteins and Peptides Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral Proteins and Peptides Sales in Volume by Type (2016-2026)
5.2 Global Oral Proteins and Peptides Revenue by Type (2016-2026)
5.3 Global Oral Proteins and Peptides Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral Proteins and Peptides Sales in Volume by Application (2016-2026)
6.2 Global Oral Proteins and Peptides Revenue by Application (2016-2026)
6.3 Global Oral Proteins and Peptides Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral Proteins and Peptides Sales by Type (2016-2026)
7.2 North America Oral Proteins and Peptides Sales by Application (2016-2026)
7.3 North America Oral Proteins and Peptides Market Size by Country
7.3.1 North America Oral Proteins and Peptides Sales in Volume by Country (2016-2026)
7.3.2 North America Oral Proteins and Peptides Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Proteins and Peptides Sales by Type (2016-2026)
8.2 Europe Oral Proteins and Peptides Sales by Application (2016-2026)
8.3 Europe Oral Proteins and Peptides Market Size by Country
8.3.1 Europe Oral Proteins and Peptides Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral Proteins and Peptides Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral Proteins and Peptides Sales by Type (2016-2026)
9.2 Asia-Pacific Oral Proteins and Peptides Sales by Application (2016-2026)
9.3 Asia-Pacific Oral Proteins and Peptides Market Size by Region
9.3.1 Asia-Pacific Oral Proteins and Peptides Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral Proteins and Peptides Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral Proteins and Peptides Sales by Type (2016-2026)
10.2 South America Oral Proteins and Peptides Sales by Application (2016-2026)
10.3 South America Oral Proteins and Peptides Market Size by Country
10.3.1 South America Oral Proteins and Peptides Sales in Volume by Country (2016-2026)
10.3.2 South America Oral Proteins and Peptides Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Proteins and Peptides Sales by Type (2016-2026)
11.2 Middle East & Africa Oral Proteins and Peptides Sales by Application (2016-2026)
11.3 Middle East & Africa Oral Proteins and Peptides Market Size by Country
11.3.1 Middle East & Africa Oral Proteins and Peptides Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral Proteins and Peptides Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral Proteins and Peptides Typical Distributors
12.3 Oral Proteins and Peptides Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oral Proteins and Peptides Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral Proteins and Peptides Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Oral Proteins and Peptides Product and Services
Table 6. Allergan Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Oral Proteins and Peptides Product and Services
Table 10. AstraZeneca Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biocon Basic Information, Manufacturing Base and Competitors
Table 12. Biocon Major Business
Table 13. Biocon Oral Proteins and Peptides Product and Services
Table 14. Biocon Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Generex Biotechnology Basic Information, Manufacturing Base and Competitors
Table 16. Generex Biotechnology Major Business
Table 17. Generex Biotechnology Oral Proteins and Peptides Product and Services
Table 18. Generex Biotechnology Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 20. Novo Nordisk Major Business
Table 21. Novo Nordisk Oral Proteins and Peptides Product and Services
Table 22. Novo Nordisk Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Synergy Pharmaceuticals Major Business
Table 25. Synergy Pharmaceuticals Oral Proteins and Peptides Product and Services
Table 26. Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Tarsa Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Tarsa Therapeutics Major Business
Table 29. Tarsa Therapeutics Oral Proteins and Peptides Product and Services
Table 30. Tarsa Therapeutics Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Oral Proteins and Peptides Product and Services
Table 34. Sanofi Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 36. Hoffmann-La Roche Major Business
Table 37. Hoffmann-La Roche Oral Proteins and Peptides Product and Services
Table 38. Hoffmann-La Roche Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table 40. Synthetic Biologics Major Business
Table 41. Synthetic Biologics Oral Proteins and Peptides Product and Services
Table 42. Synthetic Biologics Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hovione Basic Information, Manufacturing Base and Competitors
Table 44. Hovione Major Business
Table 45. Hovione Oral Proteins and Peptides Product and Services
Table 46. Hovione Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Novartis Basic Information, Manufacturing Base and Competitors
Table 48. Novartis Major Business
Table 49. Novartis Oral Proteins and Peptides Product and Services
Table 50. Novartis Oral Proteins and Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Oral Proteins and Peptides Sales by Manufacturer (2019-2021e) & (K MT)
Table 52. Global Oral Proteins and Peptides Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Oral Proteins and Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Oral Proteins and Peptides Production Capacity by Company, (K MT): 2020 VS 2021
Table 55. Head Office and Oral Proteins and Peptides Production Site of Key Manufacturer
Table 56. Oral Proteins and Peptides New Entrant and Capacity Expansion Plans
Table 57. Oral Proteins and Peptides Mergers & Acquisitions in the Past Five Years
Table 58. Global Oral Proteins and Peptides Sales by Region (2016-2021e) & (K MT)
Table 59. Global Oral Proteins and Peptides Sales by Region (2021-2026) & (K MT)
Table 60. Global Oral Proteins and Peptides Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Oral Proteins and Peptides Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Oral Proteins and Peptides Sales by Type (2016-2021e) & (K MT)
Table 63. Global Oral Proteins and Peptides Sales by Type (2021-2026) & (K MT)
Table 64. Global Oral Proteins and Peptides Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Oral Proteins and Peptides Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Oral Proteins and Peptides Price by Type (2016-2021e) & (USD/MT)
Table 67. Global Oral Proteins and Peptides Price by Type (2021-2026) & (USD/MT)
Table 68. Global Oral Proteins and Peptides Sales by Application (2016-2021e) & (K MT)
Table 69. Global Oral Proteins and Peptides Sales by Application (2021-2026) & (K MT)
Table 70. Global Oral Proteins and Peptides Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Oral Proteins and Peptides Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Oral Proteins and Peptides Price by Application (2016-2021e) & (USD/MT)
Table 73. Global Oral Proteins and Peptides Price by Application (2021-2026) & (USD/MT)
Table 74. North America Oral Proteins and Peptides Sales by Country (2016-2021e) & (K MT)
Table 75. North America Oral Proteins and Peptides Sales by Country (2021-2026) & (K MT)
Table 76. North America Oral Proteins and Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Oral Proteins and Peptides Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Oral Proteins and Peptides Sales by Type (2016-2021e) & (K MT)
Table 79. North America Oral Proteins and Peptides Sales by Type (2021-2026) & (K MT)
Table 80. North America Oral Proteins and Peptides Sales by Application (2016-2021e) & (K MT)
Table 81. North America Oral Proteins and Peptides Sales by Application (2021-2026) & (K MT)
Table 82. Europe Oral Proteins and Peptides Sales by Country (2016-2021e) & (K MT)
Table 83. Europe Oral Proteins and Peptides Sales by Country (2021-2026) & (K MT)
Table 84. Europe Oral Proteins and Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Oral Proteins and Peptides Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Oral Proteins and Peptides Sales by Type (2016-2021e) & (K MT)
Table 87. Europe Oral Proteins and Peptides Sales by Type (2021-2026) & (K MT)
Table 88. Europe Oral Proteins and Peptides Sales by Application (2016-2021e) & (K MT)
Table 89. Europe Oral Proteins and Peptides Sales by Application (2021-2026) & (K MT)
Table 90. Asia-Pacific Oral Proteins and Peptides Sales by Region (2016-2021e) & (K MT)
Table 91. Asia-Pacific Oral Proteins and Peptides Sales by Region (2021-2026) & (K MT)
Table 92. Asia-Pacific Oral Proteins and Peptides Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Oral Proteins and Peptides Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Oral Proteins and Peptides Sales by Type (2016-2021e) & (K MT)
Table 95. Asia-Pacific Oral Proteins and Peptides Sales by Type (2021-2026) & (K MT)
Table 96. Asia-Pacific Oral Proteins and Peptides Sales by Application (2016-2021e) & (K MT)
Table 97. Asia-Pacific Oral Proteins and Peptides Sales by Application (2021-2026) & (K MT)
Table 98. South America Oral Proteins and Peptides Sales by Country (2016-2021e) & (K MT)
Table 99. South America Oral Proteins and Peptides Sales by Country (2021-2026) & (K MT)
Table 100. South America Oral Proteins and Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Oral Proteins and Peptides Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Oral Proteins and Peptides Sales by Type (2016-2021e) & (K MT)
Table 103. South America Oral Proteins and Peptides Sales by Type (2021-2026) & (K MT)
Table 104. South America Oral Proteins and Peptides Sales by Application (2016-2021e) & (K MT)
Table 105. South America Oral Proteins and Peptides Sales by Application (2021-2026) & (K MT)
Table 106. Middle East & Africa Oral Proteins and Peptides Sales by Country (2016-2021e) & (K MT)
Table 107. Middle East & Africa Oral Proteins and Peptides Sales by Country (2021-2026) & (K MT)
Table 108. Middle East & Africa Oral Proteins and Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Oral Proteins and Peptides Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Oral Proteins and Peptides Sales by Type (2016-2021e) & (K MT)
Table 111. Middle East & Africa Oral Proteins and Peptides Sales by Type (2021-2026) & (K MT)
Table 112. Middle East & Africa Oral Proteins and Peptides Sales by Application (2016-2021e) & (K MT)
Table 113. Middle East & Africa Oral Proteins and Peptides Sales by Application (2021-2026) & (K MT)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Oral Proteins and Peptides Typical Distributors
Table 117. Oral Proteins and Peptides Typical Customers
List of Figures
Figure 1. Oral Proteins and Peptides Picture
Figure 2. Global Oral Proteins and Peptides Sales Market Share by Type in 2020
Figure 3. Linaclotide
Figure 4. Calcitonin
Figure 5. Insulin
Figure 6. Octreotide
Figure 7. Global Oral Proteins and Peptides Sales Market Share by Application in 2020
Figure 8. Gastric & Digestive Disorders
Figure 9. Bone Diseases
Figure 10. Diabetes
Figure 11. Hormonal Disorders
Figure 12. Global Oral Proteins and Peptides Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 13. Global Oral Proteins and Peptides Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Oral Proteins and Peptides Sales (2016-2026) & (K MT)
Figure 15. Global Oral Proteins and Peptides Price by Type (2016-2026) & (USD/MT)
Figure 16. Global Oral Proteins and Peptides Production Capacity (2016-2026) & (K MT)
Figure 17. Global Oral Proteins and Peptides Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Oral Proteins and Peptides Market Drivers
Figure 19. Oral Proteins and Peptides Market Restraints
Figure 20. Oral Proteins and Peptides Market Trends
Figure 21. Global Oral Proteins and Peptides Sales Market Share by Manufacturer in 2020
Figure 22. Global Oral Proteins and Peptides Revenue Market Share by Manufacturer in 2020
Figure 23. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Oral Proteins and Peptides Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Oral Proteins and Peptides Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Oral Proteins and Peptides Sales Market Share by Region (2016-2026)
Figure 27. Global Oral Proteins and Peptides Revenue Market Share by Region (2016-2026)
Figure 28. North America Oral Proteins and Peptides Revenue (2016-2026) & (USD Million)
Figure 29. Europe Oral Proteins and Peptides Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Oral Proteins and Peptides Revenue (2016-2026) & (USD Million)
Figure 31. South America Oral Proteins and Peptides Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Oral Proteins and Peptides Revenue (2016-2026) & (USD Million)
Figure 33. Global Oral Proteins and Peptides Sales Market Share by Type (2016-2026)
Figure 34. Global Oral Proteins and Peptides Revenue Market Share by Type (2016-2026)
Figure 35. Global Oral Proteins and Peptides Price by Type (2016-2026) & (USD/MT)
Figure 36. Global Oral Proteins and Peptides Sales Market Share by Application (2016-2026)
Figure 37. Global Oral Proteins and Peptides Revenue Market Share by Application (2016-2026)
Figure 38. Global Oral Proteins and Peptides Price by Application (2016-2026) & (USD/MT)
Figure 39. North America Oral Proteins and Peptides Sales Market Share by Type (2016-2026)
Figure 40. North America Oral Proteins and Peptides Sales Market Share by Application (2016-2026)
Figure 41. North America Oral Proteins and Peptides Sales Market Share by Country (2016-2026)
Figure 42. North America Oral Proteins and Peptides Revenue Market Share by Country (2016-2026)
Figure 43. United States Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Oral Proteins and Peptides Sales Market Share by Type (2016-2026)
Figure 47. Europe Oral Proteins and Peptides Sales Market Share by Application (2016-2026)
Figure 48. Europe Oral Proteins and Peptides Sales Market Share by Country (2016-2026)
Figure 49. Europe Oral Proteins and Peptides Revenue Market Share by Country (2016-2026)
Figure 50. Germany Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Oral Proteins and Peptides Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Oral Proteins and Peptides Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Oral Proteins and Peptides Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Oral Proteins and Peptides Revenue Market Share by Region (2016-2026)
Figure 59. China Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Oral Proteins and Peptides Sales Market Share by Type (2016-2026)
Figure 66. South America Oral Proteins and Peptides Sales Market Share by Application (2016-2026)
Figure 67. South America Oral Proteins and Peptides Sales Market Share by Country (2016-2026)
Figure 68. South America Oral Proteins and Peptides Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Oral Proteins and Peptides Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Oral Proteins and Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
骨形成プロテインの世界市場2018-2025 Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue arch…- 世界の抗菌ペプチド入り動物飼料市場 2021：企業別、地域別、種類・用途別 The Animal Feed with Antimicrobial Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のアミロイドペプチド市場 2021：企業別、地域別、種類・用途別 The Amyloid Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のホストディフェンスペプチド（HDP）市場 2021：企業別、地域別、種類・用途別 The Host Defense Peptides (HDPs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 経口血糖降下薬とインスリンアナログの世界市場2018-2025 This study researches the market size of Oral hypoglycemic agents and insulin analogues, presents the global Oral hypoglycemic agents and insulin analogues sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuse…